ShardaCare Healthcity in Collaboration with GIFT Hosts Thalassaemia Awareness Program with a Free HLA Testing Camp: Giving Children a Chance at Cure

▴ Free HLA Testing Camp
ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a Bone Marrow Transplant (BMT) Awareness Program and Free Human Leukocyte Antigen (HLA) Testing Camp in collaboration with the Globally Integrated Foundation for Thalassaemia (GIFT).

Greater Noida, January 13th 2026: ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a Bone Marrow Transplant (BMT) Awareness Program and Free Human Leukocyte Antigen (HLA) Testing Camp in collaboration with the Globally Integrated Foundation for Thalassaemia (GIFT). The camp will be led by Dr. Pawan Kumar Singh, Senior Specialist in Blood Disorders and Bone Marrow Transplantation. The awareness session will educate families about thalassaemia, available treatment options, such as bone marrow transplant, and the importance of early intervention. The free HLA testing camp will aim to identify suitable sibling donors - an essential factor for successful transplantation.

Thalassaemia is a serious paediatric blood disorder with far-reaching health implications. As a genetic condition, it often requires affected children to undergo lifelong, regular blood transfusions, placing a significant physical, emotional, and financial burden on families. India carries a substantial share of the global thalassaemia burden, with an estimated 10,000–15,000 children born with thalassaemia major every year. Despite this, limited awareness, delayed diagnosis, and restricted access to advanced treatments - such as Bone Marrow Transplant (BMT)- continue to pose major challenges. Encouragingly, medical advancements like BMT offer a curative option, holding the potential to free children from lifelong transfusions and dramatically improve their quality of life.

Dr Kousar Shah, Group CEO, Shardacare Healthcity, said,”At ShardaCare Healthcity, our mission has always been to bridge the gap between advanced Healthcare and the people who need it most. Thalassaemia is a daunting challenge for any family, but with the right clinical expertise and timely intervention, it is a challenge that we can overcome. By hosting this HLA testing camp, we are not just providing a diagnostic service; we are providing a pathway to cure. We remain steadfast in our commitment to making high-end super-speciality treatments like Bone Marrow Transplants accessible and affordable, ensuring that every child has the opportunity to lead a life free from the burden of chronic illness.”

Dr. Pawan Kumar Singh, Senior Specialist in Blood Disorders and Bone Marrow Transplantation, said, “Blood disorders such as thalassaemia is not just a complex medical condition - they place an immense emotional and financial strain on families. While Bone Marrow Transplant offers a life-changing and potentially curative solution, many children continue to remain undiagnosed or untreated due to limited awareness and access to resources. Through timely diagnosis, increased awareness, and improved access to care, we can give these children a real chance at a healthier and brighter future”.

Adding to this, Madan Chawla, Founder, GIFT, said, “The very first and most critical step towards a bone marrow transplant is HLA testing. Unfortunately, this test is expensive and out of reach for many families. Without HLA testing, a transplant is simply not possible. Through this camp, our aim is to remove this barrier and offer free HLA testing to economically weaker families, enabling them to take the first step towards a cure.”

This initiative marks a significant step towards reducing the treatment gap for thalassaemia patients and reinforcing the commitment of GIFT and Sharda Care Health City towards inclusive and compassionate healthcare.

The camp is on Saturday, 17 January 2026, at 10:00 a.m., at Shardacare Healthcity, Greater Noida. Registration is mandatory for thalassaemic children and their families to participate in the camp. Interested families can register and seek further information by contacting Madan Chawla, Founder, GIFT, via WhatsApp at +91 9811089975.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026